Free Trial
→ White House to reset Social Security? (From Altimetry) (Ad) Buy CDNA Stock  Free CDNA Stock Alerts

CareDx (CDNA) Financials

CareDx logo
$16.95 -0.16 (-0.94%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$16.92 -0.02 (-0.15%)
As of 05/23/2025 04:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for CareDx

Annual Income Statements for CareDx

This table shows CareDx's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Income / (Loss) Attributable to Common Shareholders		 53 -190 -77 -31 -19 -22 -47 -55 -39 -14 0.78
Consolidated Net Income / (Loss)		 53 -190 -77 -31 -19 -22 -47 -56 -40 -14 0.78
Net Income / (Loss) Continuing Operations		 53 -190 -77 -31 -19 -22 -47 -56 -40 -14 0.78
Total Pre-Tax Income 		53 -190 -76 -32 -20 -24 -48 -57 -41 -14 -0.72
Total Operating Income		 41 -203 -77 -30 -23 -25 -16 -20 -37 -12 1.25
Total Gross Profit		 224 178 210 199 129 82 44 27 20 18 19
Total Revenue		 334 280 322 296 192 127 77 48 41 28 27
Operating Revenue		 334 280 322 296 192 127 77 48 41 28 27
Total Cost of Revenue		 110 102 112 97 63 45 33 21 21 10 8.54
Operating Cost of Revenue		 110 102 112 97 63 45 33 21 21 10 8.54
Total Operating Expenses		 183 382 287 229 152 106 59 47 57 30 18
Selling, General & Admin Expense		 124 118 100 75 49 37 23 20 21 12 8.44
Marketing Expense		 82 83 96 77 54 39 22 13 11 8.35 6.47
Research & Development Expense		 72 82 90 77 49 31 15 12 12 9.33 3.85
Restructuring Charge		 1.78 2.32 0.00 0.00 - - - - - - -
Other Special Charges / (Income)		 -96 96 0.00 0.00 - - - - -0.46 -0.13 -1.24
Total Other Income / (Expense), net		 12 13 1.00 -2.36 2.78 0.59 -33 -37 -4.03 -1.78 -1.97
Interest & Investment Income		 12 12 3.76 0.16 0.27 0.99 -3.70 -5.86 -1.86 -1.59 -
Other Income / (Expense), net		 0.33 1.35 -2.77 -2.52 2.51 -0.40 -23 -31 -2.17 -0.19 0.15
Income Tax Expense		 0.31 0.14 0.38 -1.43 -1.04 -1.98 -1.43 -1.71 -1.61 0.00 -1.50
Basic Earnings per Share		 $1.00 ($3.54) ($1.44) ($0.59) ($0.40) ($0.52) ($1.31) ($2.38) ($2.39) ($1.16) $0.13
Weighted Average Basic Shares Outstanding		 52.77M 53.76M 53.32M 52.24M 46.48M 42.15M 35.64M 23.33M 16.50M 11.86M 5.82M
Diluted Earnings per Share		 $0.93 ($3.54) ($1.44) ($0.59) ($0.40) ($0.52) ($1.31) ($2.38) ($2.39) ($1.16) $0.10
Weighted Average Diluted Shares Outstanding		 56.62M 53.76M 53.32M 52.24M 46.48M 42.15M 35.64M 23.33M 16.50M 11.86M 9.28M
Weighted Average Basic & Diluted Shares Outstanding		 55.43M 51.78M 53.67M 53.03M 51.82M 42.88M 35.70M 23.30M 16.50M 11.80M 6M

Quarterly Income Statements for CareDx

This table shows CareDx's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders		 -10 78 -7.41 -1.39 -17 -118 -23 -25 -24 -18 -17
Consolidated Net Income / (Loss)		 -10 78 -7.41 -1.39 -17 -118 -23 -25 -24 -18 -17
Net Income / (Loss) Continuing Operations		 -10 78 -7.41 -1.39 -17 -118 -23 -25 -24 -18 -17
Total Pre-Tax Income 		-10 78 -7.21 -1.37 -17 -118 -24 -25 -24 -18 -17
Total Operating Income		 -13 75 -10 -4.10 -19 -123 -29 -28 -24 -19 -17
Total Gross Profit		 56 58 55 64 46 40 43 44 51 53 51
Total Revenue		 85 87 83 92 72 66 67 70 77 82 79
Operating Revenue		 85 87 83 92 72 66 67 70 77 82 79
Total Cost of Revenue		 28 28 28 28 26 26 25 26 26 29 28
Operating Cost of Revenue		 28 28 28 28 26 26 25 26 26 29 28
Total Operating Expenses		 70 -16 66 68 65 163 71 72 76 72 68
Selling, General & Admin Expense		 23 41 29 28 27 27 34 29 28 25 24
Marketing Expense		 23 21 20 21 20 20 18 22 23 24 22
Research & Development Expense		 19 17 17 20 19 18 19 20 24 24 22
Other Special Charges / (Income)		 5.36 - - - - - - - - - -
Total Other Income / (Expense), net		 3.08 3.49 3.28 2.73 2.60 4.70 5.22 2.60 0.70 0.96 0.67
Interest & Investment Income		 2.78 3.05 3.00 2.83 2.89 3.16 3.17 2.87 2.67 1.87 1.23
Other Income / (Expense), net		 0.30 0.44 0.28 -0.10 -0.29 1.54 2.05 -0.27 -1.97 -0.91 -0.56
Income Tax Expense		 0.06 0.17 0.20 0.02 -0.08 0.17 -0.08 -0.07 0.12 0.17 0.27
Basic Earnings per Share		 ($0.19) $1.49 ($0.14) ($0.03) ($0.32) ($2.21) ($0.43) ($0.46) ($0.44) ($0.34) ($0.32)
Weighted Average Basic Shares Outstanding		 55.26M 52.77M 52.90M 52.20M 51.69M 53.76M 54.18M 53.85M 53.64M 53.32M 53.49M
Diluted Earnings per Share		 ($0.19) $1.42 ($0.14) ($0.03) ($0.32) ($2.21) ($0.43) ($0.46) ($0.44) ($0.34) ($0.32)
Weighted Average Diluted Shares Outstanding		 55.26M 56.62M 52.90M 52.20M 51.69M 53.76M 54.18M 53.85M 53.64M 53.32M 53.49M
Weighted Average Basic & Diluted Shares Outstanding		 55.68M 55.43M 53.63M 52.74M 52.08M 51.78M 54.10M 54.17M 53.79M 53.67M 53.54M

Annual Cash Flow Statements for CareDx

This table details how cash moves in and out of CareDx's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Change in Cash & Equivalents		 32 -7.66 -258 214 96 -25 38 8.97 -13 -6.54 31
Net Cash From Operating Activities		 38 -18 -25 -19 33 -2.77 -4.01 -14 -17 -9.75 -3.35
Net Cash From Continuing Operating Activities		 38 -18 -25 -19 33 -2.77 -4.01 -14 -17 -9.75 -3.35
Net Income / (Loss) Continuing Operations		 53 -190 -77 -31 -19 -22 -47 -56 -40 -14 0.78
Consolidated Net Income / (Loss)		 53 -190 -77 -31 -19 -22 -47 -56 -40 -14 0.78
Depreciation Expense		 14 14 12 8.80 7.01 5.52 4.22 3.73 2.92 0.80 0.51
Amortization Expense		 6.18 0.51 4.80 4.22 2.54 1.62 2.47 3.87 4.03 0.12 0.07
Non-Cash Adjustments To Reconcile Net Income		 66 48 48 40 25 22 36 34 15 1.34 -1.19
Changes in Operating Assets and Liabilities, net		 -101 109 -13 -42 18 -10 0.15 0.05 1.02 1.70 -3.53
Net Cash From Investing Activities		 -0.48 40 -229 48 -100 -23 -7.93 -6.11 -21 -1.20 -1.33
Net Cash From Continuing Investing Activities		 -0.48 40 -229 48 -100 -23 -7.93 -6.11 -21 -1.20 -1.33
Purchase of Property, Plant & Equipment		 -6.48 -8.34 -21 -14 -7.11 -2.20 -2.04 -0.19 -0.55 -1.20 -0.73
Acquisitions		 0.00 -7.58 -3.71 -22 -3.25 -20 -5.89 -5.92 0.00 - -0.60
Purchase of Investments		 -161 -202 -315 -5.50 -90 0.00 0.00 - - - -
Sale and/or Maturity of Investments		 167 258 112 89 0.00 0.00 - - - - -
Net Cash From Financing Activities		 -5.61 -30 -4.54 186 163 -0.13 50 29 25 4.41 36
Net Cash From Continuing Financing Activities		 -5.61 -30 -4.54 186 163 -0.13 50 29 25 4.41 36
Repurchase of Common Equity		 -0.52 -28 -0.64 0.00 0.00 - - - - - -3.73
Issuance of Common Equity		 1.40 1.50 2.23 191 160 0.76 53 18 8.23 0.20 39
Other Financing Activities, net		 -6.48 -3.56 -6.12 -5.29 3.83 -0.72 12 1.25 0.02 0.05 0.02
Effect of Exchange Rate Changes		 0.53 -0.11 0.02 -0.30 0.27 - 0.00 - - 0.00 0.00
Cash Interest Paid		 0.00 0.00 0.01 0.00 0.01 0.02 1.77 3.27 0.87 1.36 1.21
Cash Income Taxes Paid		 0.32 0.74 0.39 0.01 0.08 0.00 0.00 - - - -

Quarterly Cash Flow Statements for CareDx

This table details how cash moves in and out of CareDx's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents		 -26 19 -0.38 2.49 11 6.22 -12 13 -15 7.29 -84
Net Cash From Operating Activities		 -27 22 13 19 -15 -8.38 -10 -0.50 0.67 7.19 -7.08
Net Cash From Continuing Operating Activities		 -27 22 13 19 -15 -8.38 -10 -0.50 0.67 7.19 -7.08
Net Income / (Loss) Continuing Operations		 -10 78 -7.41 -1.39 -17 -118 -23 -25 -24 -18 -17
Consolidated Net Income / (Loss)		 -10 78 -7.41 -1.39 -17 -118 -23 -25 -24 -18 -17
Depreciation Expense		 3.60 3.36 3.47 3.54 3.82 3.63 3.66 3.67 3.43 3.21 3.03
Amortization Expense		 2.18 0.77 1.78 0.78 2.85 -0.10 0.05 -0.00 0.56 0.69 1.75
Non-Cash Adjustments To Reconcile Net Income		 8.92 26 14 13 13 8.50 11 13 16 13 12
Changes in Operating Assets and Liabilities, net		 -31 -87 0.99 2.85 -19 98 -1.34 8.15 4.78 8.55 -6.67
Net Cash From Investing Activities		 1.33 -2.11 -14 -12 28 41 -1.50 15 -15 2.48 -76
Net Cash From Continuing Investing Activities		 1.33 -2.11 -14 -12 28 41 -1.50 15 -15 2.48 -76
Purchase of Property, Plant & Equipment		 -1.63 -1.52 -1.69 -1.79 -1.49 -1.59 -1.62 -2.36 -2.77 -3.28 -4.85
Purchase of Investments		 -52 -18 -50 -35 -58 -9.03 -58 -49 -86 -32 -101
Sale and/or Maturity of Investments		 55 17 37 26 87 52 61 67 79 37 31
Net Cash From Financing Activities		 -0.64 -0.90 1.42 -4.85 -1.28 -27 -0.03 -1.57 -1.14 -2.37 -1.03
Net Cash From Continuing Financing Activities		 -0.64 -0.90 1.42 -4.85 -1.28 -27 -0.03 -1.57 -1.14 -2.37 -1.03
Repurchase of Common Equity		 0.00 - - - -0.52 -26 -0.81 -0.07 -0.69 -0.64 -
Issuance of Common Equity		 0.87 - 0.87 - 0.53 - 1.04 - 0.46 -0.00 1.23
Other Financing Activities, net		 -1.52 -0.90 0.56 -4.85 -1.29 -0.91 -0.25 -1.50 -0.90 -1.73 -2.26
Effect of Exchange Rate Changes		 -0.08 0.41 0.08 0.02 0.03 0.11 -0.11 -0.09 -0.03 -0.00 -0.03

Annual Balance Sheets for CareDx

This table presents CareDx's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Assets		 491 467 543 567 369 152 131 84 77 56 61
Total Current Assets		 352 314 388 433 273 72 81 27 27 34 40
Cash & Equivalents		 115 82 90 348 135 38 65 17 17 30 36
Short-Term Investments		 146 153 203 0.00 90 0.00 - - - - -
Accounts Receivable		 65 51 66 60 35 24 9.76 2.99 2.77 2.37 2.69
Inventories, net		 20 19 19 17 10 6.01 4.94 5.53 5.46 0.77 0.69
Prepaid Expenses		 7.07 7.76 9.22 7.93 3.76 3.63 1.80 1.35 1.19 1.34 0.54
Plant, Property, & Equipment, net		 34 35 0.00 0.00 0.00 0.00 0.00 2.08 2.93 2.43 1.97
Total Noncurrent Assets		 106 118 155 133 95 80 50 55 47 19 19
Goodwill		 40 40 38 37 24 24 12 12 14 12 12
Intangible Assets		 38 46 43 50 44 46 33 33 33 6.65 6.65
Other Noncurrent Operating Assets		 27 31 74 46 27 10 4.13 - 0.02 0.20 0.17
Other Noncurrent Nonoperating Assets		 0.59 0.59 0.52 0.21 0.27 0.26 0.19 9.58 0.14 - -
Total Liabilities & Shareholders' Equity		 491 467 543 567 369 152 131 84 77 56 61
Total Liabilities		 113 205 112 101 91 53 35 90 57 26 20
Total Current Liabilities		 89 78 76 77 69 35 20 43 41 10 11
Accounts Payable		 7.69 13 9.94 13 9.65 5.51 4.71 3.39 3.07 1.64 1.13
Accrued Expenses		 43 45 49 38 21 17 5.64 3.74 5.58 3.13 1.86
Current Employee Benefit Liabilities		 38 20 17 26 18 12 9.16 5.01 3.85 2.37 1.68
Total Noncurrent Liabilities		 23 127 36 23 22 18 15 47 16 16 8.71
Noncurrent Deferred & Payable Income Tax Liabilities		 0.16 0.14 0.00 0.42 1.30 1.97 2.97 4.93 6.06 0.00 -
Other Noncurrent Operating Liabilities		 23 127 36 23 20 16 12 22 6.92 0.98 1.10
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 378 261 431 466 278 99 96 -5.95 20 29 41
Total Preferred & Common Equity		 378 261 431 466 278 99 96 -6.13 19 29 41
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 378 261 431 466 278 99 96 -6.13 19 29 41
Common Stock		 1,013 947 899 854 632 438 412 264 236 203 201
Retained Earnings		 -626 -678 -460 -383 -353 -334 -312 -268 -213 -173 -159
Accumulated Other Comprehensive Income / (Loss)		 -8.57 -6.96 -7.50 -4.67 -2.10 -5.21 -4.28 -2.35 -3.66 0.00 -

Quarterly Balance Sheets for CareDx

This table presents CareDx's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/31/2025 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets		 490 477 467 452 501 515 528 545
Total Current Assets		 350 334 321 303 345 361 371 388
Cash & Equivalents		 89 95 96 93 76 88 75 83
Short-Term Investments		 142 145 133 123 192 195 211 208
Accounts Receivable		 71 67 66 60 52 52 59 70
Inventories, net		 23 19 19 20 18 19 18 18
Prepaid Expenses		 25 7.34 6.34 6.90 7.31 7.68 8.16 8.37
Plant, Property, & Equipment, net		 33 34 34 34 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 107 109 112 115 156 154 157 156
Goodwill		 40 40 40 40 40 40 40 38
Intangible Assets		 37 40 42 43 46 44 46 44
Other Noncurrent Operating Assets		 29 28 29 31 69 70 71 75
Other Noncurrent Nonoperating Assets		 0.55 0.59 0.59 0.58 0.58 0.58 0.52 0.20
Total Liabilities & Shareholders' Equity		 490 477 467 452 501 515 528 545
Total Liabilities		 110 204 202 196 107 110 108 108
Total Current Liabilities		 85 81 78 70 73 74 72 70
Accounts Payable		 8.07 6.24 5.87 9.98 8.97 9.88 13 11
Accrued Expenses		 43 45 47 46 47 50 47 45
Current Employee Benefit Liabilities		 14 30 25 15 17 14 12 14
Other Current Liabilities		 20 - - - - - - -
Total Noncurrent Liabilities		 25 121 122 125 34 35 36 38
Noncurrent Deferred & Payable Income Tax Liabilities		 0.13 0.20 0.05 0.04 0.14 0.05 - 0.01
Other Noncurrent Operating Liabilities		 25 121 122 125 34 35 36 38
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 379 273 265 256 394 405 420 437
Total Preferred & Common Equity		 379 273 265 256 394 405 420 437
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 379 273 265 256 394 405 420 437
Common Stock		 1,023 985 969 960 937 924 912 887
Retained Earnings		 -637 -704 -697 -695 -534 -510 -485 -441
Accumulated Other Comprehensive Income / (Loss)		 -7.09 -7.18 -7.96 -8.11 -8.67 -8.45 -7.44 -8.81

Annual Metrics And Ratios for CareDx

This table displays calculated financial ratios and metrics derived from CareDx's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 19.07% -12.89% 8.57% 54.22% 51.25% 65.95% 58.45% 18.93% 44.37% 3.07% 23.57%
EBITDA Growth		 132.85% -194.21% -230.66% -83.58% 41.10% 44.50% 26.06% -33.17% -190.47% -665.72% 635.41%
EBIT Growth		 120.34% -152.53% -148.07% -61.07% 19.70% 35.63% 23.97% -28.97% -225.92% -967.57% 200.29%
NOPAT Growth		 128.47% -163.32% -159.81% -31.95% 8.17% -57.48% 23.24% 45.64% -212.87% -1,054.56% 245.86%
Net Income Growth		 127.62% -148.37% -149.86% -63.85% 14.81% 53.04% 15.80% -39.75% -190.04% -1,855.06% 122.05%
EPS Growth		 126.27% -145.83% -144.07% -47.50% 23.08% 60.31% 44.96% 0.42% -106.03% -1,260.00% 102.86%
Operating Cash Flow Growth		 306.92% 27.14% -30.81% -157.71% 1,307.33% 30.90% 71.99% 13.41% -69.43% -191.10% -513.55%
Free Cash Flow Firm Growth		 -69.02% 59.05% 13.02% -972.11% 82.92% -15.30% -485.91% 128.23% -398.86% 63.97% -546.10%
Invested Capital Growth		 362.78% -81.56% 17.17% 122.33% -12.91% 94.48% 1,808.03% -93.80% 71.26% -5.65% 411.62%
Revenue Q/Q Growth		 6.72% -5.66% 0.99% 12.16% 6.22% 10.73% 16.79% 3.52% 11.56% -4.43% 0.00%
EBITDA Q/Q Growth		 145.42% -118.37% -4.37% -399.84% 32.43% -23.60% 47.39% -49.56% -86.67% -62.11% 0.00%
EBIT Q/Q Growth		 126.49% -100.12% -3.84% -103.30% 18.71% -21.08% 43.15% -39.46% -72.26% -72.13% 0.00%
NOPAT Q/Q Growth		 136.98% -103.67% -5.06% -208.83% 67.69% -14.62% 10.73% 41.80% -62.79% -69.46% 0.00%
Net Income Q/Q Growth		 136.60% -110.22% -2.93% -70.10% 6.29% -4.85% 37.34% -40.15% -38.02% -53.13% 0.00%
EPS Q/Q Growth		 134.44% -111.98% -2.13% -78.79% 13.04% -8.33% 48.43% -46.01% -6.22% -397.44% 0.00%
Operating Cash Flow Q/Q Growth		 389.17% -551.59% 10.68% -18.52% 32.84% -987.50% 50.86% 5.99% 5.25% -50.08% 5.53%
Free Cash Flow Firm Q/Q Growth		 -196.21% 39.32% 15.71% -144.01% 83.08% -16.53% -74.68% 364.04% 10.22% 0.00% 0.00%
Invested Capital Q/Q Growth		 253.95% -79.80% -5.44% 7.84% -3.44% 7.37% -0.82% -92.03% -35.71% -1.97% 0.00%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 67.16% 63.61% 65.13% 67.14% 67.16% 64.23% 56.92% 55.78% 48.02% 63.50% 68.72%
EBITDA Margin		 18.42% -66.75% -19.76% -6.49% -5.45% -14.00% -41.86% -89.71% -80.12% -39.82% 7.25%
Operating Margin		 12.21% -72.55% -24.00% -10.03% -11.72% -19.31% -20.35% -42.00% -91.88% -42.40% 4.58%
EBIT Margin		 12.31% -72.06% -24.86% -10.88% -10.42% -19.62% -50.59% -105.43% -97.22% -43.06% 5.12%
Profit (Net Income) Margin		 15.74% -67.88% -23.81% -10.34% -9.74% -17.29% -61.10% -114.97% -97.85% -48.70% 2.86%
Tax Burden Percent		 99.41% 100.07% 100.50% 95.56% 94.75% 91.74% 97.03% 97.02% 96.12% 100.00% -108.62%
Interest Burden Percent		 128.63% 94.13% 95.30% 99.50% 98.65% 96.05% 124.48% 112.41% 104.71% 113.09% -51.47%
Effective Tax Rate		 0.59% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 56.87% -175.07% -42.49% -24.50% -27.85% -37.48% -66.59% -101.71% -125.45% -52.80% 15.83%
ROIC Less NNEP Spread (ROIC-NNEP)		 52.04% -156.97% -35.47% -21.06% -25.62% -28.19% 58.80% -687.13% 233.45% -25.45% 17.10%
Return on Net Nonoperating Assets (RNNOA)		 -40.44% 120.10% 25.40% 16.25% 17.92% 14.94% -37.40% -703.10% -35.98% 14.08% -9.78%
Return on Equity (ROE)		 16.43% -54.98% -17.09% -8.25% -9.94% -22.54% -103.99% -804.81% -161.43% -38.72% 6.05%
Cash Return on Invested Capital (CROIC)		 -72.05% -37.36% -58.30% -100.40% -14.05% -101.64% -246.67% 74.94% -177.99% -46.98% -126.72%
Operating Return on Assets (OROA)		 8.58% -40.01% -14.42% -6.90% -7.70% -17.66% -36.16% -63.57% -59.69% -20.76% 3.93%
Return on Assets (ROA)		 10.97% -37.69% -13.81% -6.56% -7.19% -15.56% -43.67% -69.32% -60.07% -23.48% 2.20%
Return on Common Equity (ROCE)		 16.43% -54.98% -17.09% -8.25% -9.94% -22.54% -103.78% -778.05% -160.51% -38.72% -25.61%
Return on Equity Simple (ROE_SIMPLE)		 13.89% -72.81% -17.78% -6.58% -6.74% -22.19% -48.77% 905.77% -204.07% -46.47% 1.89%
Net Operating Profit after Tax (NOPAT)		 41 -142 -54 -21 -16 -17 -11 -14 -26 -8.35 0.88
NOPAT Margin		 12.14% -50.78% -16.80% -7.02% -8.21% -13.51% -14.24% -29.40% -64.32% -29.68% 3.20%
Net Nonoperating Expense Percent (NNEP)		 4.84% -18.10% -7.02% -3.44% -2.24% -9.29% -125.39% 585.42% -358.89% -27.35% -1.27%
Return On Investment Capital (ROIC_SIMPLE)		 10.71% -54.47% -12.55% - - - - - - - -
Cost of Revenue to Revenue		 32.84% 36.39% 34.87% 32.86% 32.84% 35.77% 43.08% 44.22% 51.98% 36.50% 31.28%
SG&A Expenses to Revenue		 37.08% 42.05% 31.20% 25.29% 25.39% 28.76% 30.01% 41.58% 51.01% 43.52% 30.89%
R&D to Revenue		 21.69% 29.20% 28.09% 25.82% 25.46% 24.17% 18.96% 25.64% 30.48% 33.16% 14.08%
Operating Expenses to Revenue		 54.94% 136.16% 89.13% 77.17% 78.88% 83.53% 77.26% 97.77% 139.90% 105.89% 64.14%
Earnings before Interest and Taxes (EBIT)		 41 -202 -80 -32 -20 -25 -39 -51 -40 -12 1.40
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 61 -187 -64 -19 -10 -18 -32 -43 -33 -11 1.98
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.03 2.48 1.42 5.15 12.85 9.25 10.20 0.00 2.95 2.58 2.07
Price to Tangible Book Value (P/TBV)		 3.83 3.70 1.74 6.34 17.04 30.92 19.30 0.00 0.00 7.03 3.78
Price to Revenue (P/Rev)		 3.44 2.32 1.90 8.10 18.57 7.20 12.77 4.34 1.41 2.71 3.13
Price to Earnings (P/E)		 21.85 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 109.57
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 4.58% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.91%
Enterprise Value to Invested Capital (EV/IC)		 7.57 16.34 2.31 17.52 63.45 14.49 29.35 139.32 2.45 4.04 3.72
Enterprise Value to Revenue (EV/Rev)		 2.66 1.48 0.99 6.93 17.40 6.90 11.93 4.70 1.59 2.20 2.22
Enterprise Value to EBITDA (EV/EBITDA)		 14.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 30.57
Enterprise Value to EBIT (EV/EBIT)		 21.60 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 43.35
Enterprise Value to NOPAT (EV/NOPAT)		 21.90 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 69.21
Enterprise Value to Operating Cash Flow (EV/OCF)		 23.33 0.00 0.00 0.00 100.03 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 21.71 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -5.72 1.21 0.53 0.28
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -3.08 0.06 0.44 0.13
Financial Leverage		 -0.78 -0.77 -0.72 -0.77 -0.70 -0.53 -0.64 1.02 -0.15 -0.55 -0.57
Leverage Ratio		 1.50 1.46 1.24 1.26 1.38 1.45 2.38 11.61 2.69 1.65 2.75
Compound Leverage Factor		 1.93 1.37 1.18 1.25 1.36 1.39 2.96 13.05 2.81 1.87 -1.42
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 121.18% 54.79% 34.82% 21.65%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 55.94% 52.27% 6.33% 11.31%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 65.25% 2.51% 28.48% 10.34%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.64% 0.64% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% -21.83% 44.58% 65.18% 78.35%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.79 -0.74 -1.41 5.76
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.40 -0.21 1.26 -12.63
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.42 -0.03 -1.15 2.75
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.40 -0.92 -1.89 13.04
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.21 -0.26 1.69 -28.59
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.29 -0.04 -1.54 6.23
Altman Z-Score		 5.93 -0.36 2.88 14.44 23.24 7.92 13.71 -4.75 -4.66 -2.30 0.03
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.20% 3.32% 0.57% 0.00% 523.49%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.94 4.02 5.11 5.61 3.95 2.07 4.16 0.62 0.65 3.38 3.62
Quick Ratio		 3.64 3.67 4.73 5.28 3.75 1.79 3.81 0.46 0.49 3.18 3.51
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -51 -30 -74 -85 -7.95 -47 -40 10 -37 -7.43 -21
Operating Cash Flow to CapEx		 586.80% -220.37% -118.86% -142.30% 470.20% -125.81% -196.90% -7,691.94% -3,009.65% -813.34% -457.03%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -6.99 22.80 0.00 0.00 -9.75
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -0.69 -31.17 0.00 0.00 -1.58
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -1.05 -31.58 0.00 0.00 -1.93
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.70 0.56 0.58 0.63 0.74 0.90 0.71 0.60 0.61 0.48 0.77
Accounts Receivable Turnover		 5.77 4.78 5.10 6.28 6.55 7.52 12.01 16.78 15.83 11.14 11.02
Inventory Turnover		 5.63 5.27 6.16 7.16 7.88 8.30 6.30 3.89 6.78 14.15 14.19
Fixed Asset Turnover		 9.70 0.00 0.00 0.00 0.00 0.00 0.00 19.31 15.17 12.81 15.51
Accounts Payable Turnover		 10.67 8.94 9.64 8.47 8.33 8.90 8.14 6.62 8.97 7.41 9.78
Days Sales Outstanding (DSO)		 63.24 76.41 71.50 58.12 55.72 48.57 30.39 21.75 23.06 32.77 33.13
Days Inventory Outstanding (DIO)		 64.88 69.25 59.23 50.97 46.34 43.99 57.94 93.85 53.80 25.79 25.73
Days Payable Outstanding (DPO)		 34.22 40.82 37.86 43.08 43.83 41.02 44.82 55.13 40.69 49.24 37.31
Cash Conversion Cycle (CCC)		 93.90 104.84 92.87 66.00 58.23 51.54 43.50 60.47 36.18 9.32 21.55
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 117 25 137 117 53 61 31 1.63 26 15 16
Invested Capital Turnover		 4.68 3.45 2.53 3.49 3.39 2.77 4.68 3.46 1.95 1.78 4.94
Increase / (Decrease) in Invested Capital		 92 -112 20 64 -7.82 29 29 -25 11 -0.92 22
Enterprise Value (EV)		 888 414 318 2,053 3,344 877 913 227 64 62 61
Market Capitalization		 1,148 649 611 2,401 3,569 915 978 210 57 76 86
Book Value per Share		 $7.06 $4.83 $8.05 $8.82 $5.64 $2.33 $2.47 ($0.21) $0.92 $2.48 $3.50
Tangible Book Value per Share		 $5.59 $3.24 $6.54 $7.17 $4.25 $0.70 $1.30 ($1.79) ($1.29) $0.91 $1.92
Total Capital		 378 261 431 466 278 99 96 28 44 45 53
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 34 24 16 11
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 18 1.10 13 5.45
Net Debt		 -261 -235 -293 -348 -225 -38 -65 17 6.69 -14 -25
Capital Expenditures (CapEx)		 6.48 8.34 21 14 7.11 2.20 2.04 0.19 0.55 1.20 0.73
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 1.81 0.22 19 7.57 -21 -1.13 -3.01 -17 -8.57 -2.81 -1.26
Debt-free Net Working Capital (DFNWC)		 262 236 312 356 204 37 62 -0.42 8.69 27 35
Net Working Capital (NWC)		 262 236 312 356 204 37 62 -16 -14 24 29
Net Nonoperating Expense (NNE)		 -12 48 23 9.85 2.94 4.80 36 41 14 5.35 0.09
Net Nonoperating Obligations (NNO)		 -261 -236 -294 -349 -225 -38 -65 7.59 6.54 -14 -25
Total Depreciation and Amortization (D&A)		 20 15 16 13 9.54 7.14 6.68 7.60 6.95 0.91 0.58
Debt-free, Cash-free Net Working Capital to Revenue		 0.54% 0.08% 5.84% 2.56% -10.83% -0.89% -3.93% -35.83% -21.09% -9.99% -4.61%
Debt-free Net Working Capital to Revenue		 78.63% 84.06% 96.92% 120.13% 106.08% 29.19% 80.46% -0.87% 21.38% 96.21% 128.81%
Net Working Capital to Revenue		 78.63% 84.06% 96.92% 120.13% 106.08% 29.19% 80.46% -33.40% -34.85% 86.02% 106.98%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.00 ($3.54) ($1.44) ($0.59) ($0.40) ($0.52) ($1.31) ($2.38) ($2.39) ($1.16) $0.13
Adjusted Weighted Average Basic Shares Outstanding		 52.77M 53.76M 53.32M 52.24M 46.48M 42.15M 35.64M 23.33M 16.50M 11.86M 5.82M
Adjusted Diluted Earnings per Share		 $0.93 ($3.54) ($1.44) ($0.59) ($0.40) ($0.52) ($1.31) ($2.38) ($2.39) ($1.16) $0.10
Adjusted Weighted Average Diluted Shares Outstanding		 56.62M 53.76M 53.32M 52.24M 46.48M 42.15M 35.64M 23.33M 16.50M 11.86M 9.28M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 55.43M 51.78M 53.67M 53.03M 51.82M 42.88M 41.73M 29.07M 16.50M 11.97M 11.81M
Normalized Net Operating Profit after Tax (NOPAT)		 -53 -73 -54 -21 -16 -17 -11 -13 -17 -8.44 0.01
Normalized NOPAT Margin		 -16.01% -26.16% -16.80% -7.02% -8.21% -13.51% -14.24% -26.56% -42.67% -29.99% 0.03%
Pre Tax Income Margin		 15.84% -67.83% -23.69% -10.83% -10.28% -18.85% -62.97% -118.51% -101.80% -48.70% -2.63%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -6.70 -111.00 0.00 0.00 0.66
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -1.89 -30.95 0.00 0.00 0.41
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -7.05 -111.40 0.00 0.00 0.31
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -2.24 -31.35 0.00 0.00 0.07
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.99% -14.47% -0.84% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 477.98%

Quarterly Metrics And Ratios for CareDx

This table displays calculated financial ratios and metrics derived from CareDx's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 17.54% 32.04% 23.35% 31.26% -6.75% -20.41% -15.33% -12.81% -2.71% 3.99% 4.99%
EBITDA Growth		 54.88% 167.42% 78.44% 100.53% 41.91% -628.78% -75.50% -34.36% -36.68% -19.76% -49.67%
EBIT Growth		 42.78% 162.04% 61.82% 84.95% 25.35% -504.67% -49.39% -25.50% -32.46% -17.35% -48.17%
NOPAT Growth		 40.73% 186.82% 63.55% 85.17% 20.50% -541.38% -66.00% -27.19% -27.66% -24.16% -98.68%
Net Income Growth		 47.94% 166.06% 68.46% 94.41% 29.85% -544.32% -38.64% -15.01% -20.87% -13.49% -42.38%
EPS Growth		 50.00% 164.25% 67.44% 93.48% 27.27% -550.00% -34.38% -12.20% -18.92% -9.68% -39.13%
Operating Cash Flow Growth		 -73.62% 361.17% 223.02% 3,897.39% -2,381.97% -216.65% -43.79% 87.13% 103.13% 72.47% -1,953.14%
Free Cash Flow Firm Growth		 -251.47% -166.36% 27,394.31% 2,073.64% 732.63% 178.00% 99.36% 90.24% 77.08% 55.48% 19.10%
Invested Capital Growth		 260.08% 362.78% -73.59% -69.80% -69.25% -81.56% -13.66% -11.06% -3.29% 17.17% 33.64%
Revenue Q/Q Growth		 -2.19% 4.46% -10.18% 28.07% 9.88% -2.42% -4.42% -9.01% -6.22% 3.81% -1.58%
EBITDA Q/Q Growth		 -109.21% 1,696.70% -3,948.06% 101.00% 88.98% -410.57% 4.97% -8.65% -38.24% -22.95% 27.24%
EBIT Q/Q Growth		 -117.41% 835.90% -143.19% 78.61% 83.79% -352.91% 4.14% -6.09% -31.28% -11.90% 19.47%
NOPAT Q/Q Growth		 -112.56% 1,114.77% -156.03% 78.81% 84.23% -326.06% -4.20% -13.57% -27.22% -10.27% 20.17%
Net Income Q/Q Growth		 -113.27% 1,153.05% -431.42% 91.63% 85.89% -402.86% 5.88% -5.07% -29.57% -8.21% 21.93%
EPS Q/Q Growth		 -113.38% 1,114.29% -366.67% 90.63% 85.52% -413.95% 6.52% -4.55% -29.41% -6.25% 21.95%
Operating Cash Flow Q/Q Growth		 -221.45% 74.80% -33.92% 223.75% -82.70% 17.66% -1,939.88% -174.37% -90.66% 201.50% -82.59%
Free Cash Flow Firm Q/Q Growth		 -569.89% -120.42% 3.23% 4.18% 202.13% 8,500.39% 92.54% 66.61% 62.75% 31.18% -14.03%
Invested Capital Q/Q Growth		 26.18% 253.95% -10.10% -10.32% 62.17% -79.80% 2.80% -8.69% -2.72% -5.44% 5.89%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 66.45% 67.45% 66.73% 69.71% 64.01% 60.94% 63.49% 63.18% 66.39% 64.20% 64.34%
EBITDA Margin		 -8.62% 91.55% -5.99% 0.14% -17.98% -179.29% -34.27% -34.46% -28.86% -19.58% -16.53%
Operating Margin		 -15.79% 86.27% -12.66% -4.44% -26.84% -187.03% -42.84% -39.29% -31.48% -23.21% -21.85%
EBIT Margin		 -15.44% 86.77% -12.32% -4.55% -27.24% -184.68% -39.79% -39.68% -34.03% -24.31% -22.55%
Profit (Net Income) Margin		 -12.23% 90.10% -8.94% -1.51% -23.12% -180.11% -34.95% -35.49% -30.74% -22.25% -21.34%
Tax Burden Percent		 100.56% 99.78% 102.77% 101.60% 99.50% 100.14% 99.66% 99.73% 100.52% 100.95% 101.60%
Interest Burden Percent		 78.71% 104.06% 70.60% 32.68% 85.30% 97.39% 88.14% 89.71% 89.86% 90.66% 93.16%
Effective Tax Rate		 0.00% 0.22% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -40.54% 403.21% -34.98% -11.63% -59.19% -451.35% -65.86% -65.68% -51.86% -41.09% -38.39%
ROIC Less NNEP Spread (ROIC-NNEP)		 -40.09% 401.81% -34.95% -12.21% -57.95% -439.16% -64.67% -63.77% -49.64% -39.55% -36.93%
Return on Net Nonoperating Assets (RNNOA)		 28.17% -312.30% 26.65% 9.32% 42.98% 335.99% 43.61% 44.31% 34.27% 28.32% 26.61%
Return on Equity (ROE)		 -12.36% 90.91% -8.32% -2.32% -16.21% -115.35% -22.25% -21.37% -17.59% -12.76% -11.78%
Cash Return on Invested Capital (CROIC)		 -60.56% -72.05% -21.88% -46.94% -53.11% -37.36% -37.00% -36.06% -39.17% -58.30% -69.33%
Operating Return on Assets (OROA)		 -11.36% 60.48% -7.88% -2.75% -15.28% -102.53% -22.61% -23.24% -20.24% -14.10% -12.97%
Return on Assets (ROA)		 -8.99% 62.80% -5.72% -0.91% -12.97% -100.00% -19.86% -20.79% -18.28% -12.90% -12.28%
Return on Common Equity (ROCE)		 -12.36% 90.91% -8.32% -2.32% -16.21% -115.35% -22.25% -21.37% -17.59% -12.76% -11.78%
Return on Equity Simple (ROE_SIMPLE)		 16.37% 0.00% -52.54% -60.32% -71.50% 0.00% -22.97% -20.72% -19.22% 0.00% -17.05%
Net Operating Profit after Tax (NOPAT)		 -9.36 75 -7.34 -2.87 -14 -86 -20 -19 -17 -13 -12
NOPAT Margin		 -11.05% 86.08% -8.86% -3.11% -18.79% -130.92% -29.99% -27.51% -22.04% -16.25% -15.29%
Net Nonoperating Expense Percent (NNEP)		 -0.44% 1.40% -0.03% 0.58% -1.25% -12.18% -1.19% -1.90% -2.22% -1.54% -1.47%
Return On Investment Capital (ROIC_SIMPLE)		 -2.47% 19.69% - - - -32.85% - - - -3.11% -
Cost of Revenue to Revenue		 33.55% 32.55% 33.27% 30.29% 35.99% 39.06% 36.51% 36.82% 33.61% 35.80% 35.66%
SG&A Expenses to Revenue		 26.89% 46.99% 34.40% 30.00% 37.35% 40.48% 50.55% 41.72% 36.28% 30.07% 30.03%
R&D to Revenue		 21.87% 19.09% 21.10% 21.33% 25.97% 27.87% 28.28% 28.78% 31.53% 28.61% 28.11%
Operating Expenses to Revenue		 82.24% -18.82% 79.39% 74.16% 90.84% 247.96% 106.33% 102.47% 97.87% 87.41% 86.19%
Earnings before Interest and Taxes (EBIT)		 -13 75 -10 -4.20 -20 -121 -27 -28 -26 -20 -18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -7.30 79 -4.96 0.13 -13 -118 -23 -24 -22 -16 -13
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.59 3.03 6.03 3.06 2.14 2.48 0.96 1.13 1.17 1.42 2.08
Price to Tangible Book Value (P/TBV)		 3.26 3.83 8.55 4.43 3.18 3.70 1.23 1.42 1.47 1.74 2.56
Price to Revenue (P/Rev)		 2.84 3.44 5.27 2.72 1.99 2.32 1.28 1.48 1.53 1.90 2.86
Price to Earnings (P/E)		 15.85 21.85 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 6.31% 4.58% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 5.09 7.57 42.46 15.75 8.09 16.34 0.89 1.43 1.53 2.31 4.26
Enterprise Value to Revenue (EV/Rev)		 2.17 2.66 4.50 1.95 1.21 1.48 0.37 0.56 0.64 0.99 1.94
Enterprise Value to EBITDA (EV/EBITDA)		 10.70 14.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 14.80 21.60 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 15.18 21.90 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 28.12 23.33 180.76 0.00 0.00 0.00 0.00 627.94 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.70 -0.78 -0.76 -0.76 -0.74 -0.77 -0.67 -0.69 -0.69 -0.72 -0.72
Leverage Ratio		 1.48 1.50 1.47 1.47 1.45 1.46 1.26 1.24 1.22 1.24 1.22
Compound Leverage Factor		 1.17 1.56 1.03 0.48 1.24 1.42 1.11 1.12 1.10 1.12 1.14
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 4.80 6.16 4.00 1.54 0.61 0.21 1.70 2.21 2.56 3.24 5.10
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 4.11 3.94 4.10 4.09 4.32 4.02 4.75 4.84 5.17 5.11 5.52
Quick Ratio		 3.55 3.64 3.78 3.77 3.93 3.67 4.40 4.49 4.81 4.73 5.15
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -116 -17 85 82 79 26 -0.31 -4.17 -12 -34 -49
Operating Cash Flow to CapEx		 -1,630.92% 1,438.17% 743.15% 1,058.60% -1,029.72% -525.78% -629.50% -21.13% 24.22% 219.26% -146.08%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.74 0.70 0.64 0.61 0.56 0.56 0.57 0.59 0.59 0.58 0.58
Accounts Receivable Turnover		 5.26 5.77 5.29 5.04 4.61 4.78 4.87 5.08 5.13 5.10 5.03
Inventory Turnover		 5.21 5.63 5.75 5.46 5.35 5.27 5.87 5.82 6.14 6.16 5.95
Fixed Asset Turnover		 10.32 9.70 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 12.42 10.67 14.08 13.21 8.93 8.94 10.81 8.19 9.49 9.64 8.60
Days Sales Outstanding (DSO)		 69.35 63.24 69.04 72.36 79.25 76.41 75.00 71.85 71.16 71.50 72.52
Days Inventory Outstanding (DIO)		 70.09 64.88 63.48 66.80 68.28 69.25 62.16 62.75 59.41 59.23 61.35
Days Payable Outstanding (DPO)		 29.38 34.22 25.93 27.64 40.87 40.82 33.78 44.56 38.48 37.86 42.45
Cash Conversion Cycle (CCC)		 110.06 93.90 106.59 111.51 106.65 104.84 103.39 90.04 92.09 92.87 91.42
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 148 117 33 37 41 25 125 122 134 137 145
Invested Capital Turnover		 3.67 4.68 3.95 3.74 3.15 3.45 2.20 2.39 2.35 2.53 2.51
Increase / (Decrease) in Invested Capital		 107 92 -92 -85 -92 -112 -20 -15 -4.55 20 37
Enterprise Value (EV)		 753 888 1,406 580 332 414 111 175 205 318 619
Market Capitalization		 984 1,148 1,647 809 548 649 379 457 491 611 910
Book Value per Share		 $6.84 $7.06 $5.18 $5.08 $4.95 $4.83 $7.28 $7.53 $7.83 $8.05 $8.17
Tangible Book Value per Share		 $5.44 $5.59 $3.65 $3.50 $3.33 $3.24 $5.68 $5.99 $6.24 $6.54 $6.65
Total Capital		 379 378 273 265 256 261 394 405 420 431 437
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -231 -261 -241 -229 -216 -235 -268 -283 -286 -293 -291
Capital Expenditures (CapEx)		 1.63 1.52 1.69 1.79 1.49 1.59 1.62 2.36 2.77 3.28 4.85
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 34 1.81 12 13 17 0.22 4.31 3.65 14 19 27
Debt-free Net Working Capital (DFNWC)		 265 262 253 242 233 236 272 286 300 312 318
Net Working Capital (NWC)		 265 262 253 242 233 236 272 286 300 312 318
Net Nonoperating Expense (NNE)		 0.99 -3.48 0.06 -1.47 3.12 32 3.34 5.62 6.72 4.95 4.80
Net Nonoperating Obligations (NNO)		 -231 -261 -240 -228 -215 -236 -269 -283 -286 -294 -291
Total Depreciation and Amortization (D&A)		 5.78 4.13 5.25 4.33 6.67 3.53 3.71 3.66 3.99 3.90 4.78
Debt-free, Cash-free Net Working Capital to Revenue		 9.83% 0.54% 3.77% 4.51% 6.17% 0.08% 1.45% 1.18% 4.27% 5.84% 8.35%
Debt-free Net Working Capital to Revenue		 76.48% 78.63% 80.78% 81.55% 84.65% 84.06% 91.71% 92.57% 93.73% 96.92% 99.76%
Net Working Capital to Revenue		 76.48% 78.63% 80.78% 81.55% 84.65% 84.06% 91.71% 92.57% 93.73% 96.92% 99.76%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.19) $1.49 ($0.14) ($0.03) ($0.32) ($2.21) ($0.43) ($0.46) ($0.44) ($0.34) ($0.32)
Adjusted Weighted Average Basic Shares Outstanding		 55.26M 52.77M 52.90M 52.20M 51.69M 53.76M 54.18M 53.85M 53.64M 53.32M 53.49M
Adjusted Diluted Earnings per Share		 ($0.19) $1.42 ($0.14) ($0.03) ($0.32) ($2.21) ($0.43) ($0.46) ($0.44) ($0.34) ($0.32)
Adjusted Weighted Average Diluted Shares Outstanding		 55.26M 56.62M 52.90M 52.20M 51.69M 53.76M 54.18M 53.85M 53.64M 53.32M 53.49M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 55.68M 55.43M 53.63M 52.74M 52.08M 51.78M 54.10M 54.17M 53.79M 53.67M 53.54M
Normalized Net Operating Profit after Tax (NOPAT)		 -5.61 75 -7.34 -2.82 -14 -86 -20 -19 -17 -13 -12
Normalized NOPAT Margin		 -6.62% 86.08% -8.86% -3.06% -18.79% -130.92% -29.99% -26.66% -22.04% -16.25% -15.29%
Pre Tax Income Margin		 -12.16% 90.30% -8.70% -1.49% -23.24% -179.86% -35.07% -35.59% -30.58% -22.04% -21.01%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.99% -18.45% -17.11% -14.94% -14.47% -2.44% -1.67% -1.65% -0.84% 0.00%

Frequently Asked Questions About CareDx's Financials

When does CareDx's financial year end?

According to the most recent income statement we have on file, CareDx's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has CareDx's net income changed over the last 10 years?

CareDx's net income appears to be on an upward trend, with a most recent value of $52.55 million in 2024, rising from $781 thousand in 2014. The previous period was -$190.28 million in 2023. See where experts think CareDx is headed by visiting CareDx's forecast page.

What is CareDx's operating income?
CareDx's total operating income in 2024 was $40.77 million, based on the following breakdown:
  • Total Gross Profit: $224.16 million
  • Total Operating Expenses: $183.39 million
How has CareDx revenue changed over the last 10 years?

Over the last 10 years, CareDx's total revenue changed from $27.31 million in 2014 to $333.79 million in 2024, a change of 1,122.4%.

How much debt does CareDx have?

CareDx's total liabilities were at $112.62 million at the end of 2024, a 45.2% decrease from 2023, and a 467.5% increase since 2014.

How much cash does CareDx have?

In the past 10 years, CareDx's cash and equivalents has ranged from $16.90 million in 2017 to $348.49 million in 2021, and is currently $114.69 million as of their latest financial filing in 2024.

How has CareDx's book value per share changed over the last 10 years?

Over the last 10 years, CareDx's book value per share changed from 3.50 in 2014 to 7.06 in 2024, a change of 101.7%.


Related Companies

This page (NASDAQ:CDNA) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...
Colonial Metals | Sponsored
Trump’s Bitcoin Reserve is No Accident…
Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...
Crypto 101 Media | Sponsored
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored